CLF-065

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameCLF-065
Drug Alias NameCLF-065
ClassificationBiologics
Mechanisms of ActionGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 2 receptor
Therapy Area/IndicationsInflammatory Bowel DiseasesPouchitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalifornia Institute For Biomedical Research
China Registration ClassN/A

Develop Information

Active CompaniesThe Calibr-Skaggs Institute for Innovative MedicinesAbbvie IncCalifornia Institute For Biomedical Research
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesPouchitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A